Corcept Therapeutics Incorporated
CORT
$57.08
$5.9211.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 338.18M | 372.15M | 421.68M | 342.23M | 322.76M |
| Total Receivables | 39.07M | 59.79M | 69.63M | 64.57M | 61.82M |
| Inventory | 12.89M | 12.87M | 12.35M | 12.28M | 14.37M |
| Prepaid Expenses | 19.86M | 23.26M | 22.98M | 9.69M | 8.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.03M | 17.40M | 14.49M | 14.35M | 31.00M |
| Total Current Assets | 426.03M | 485.46M | 541.13M | 443.11M | 438.50M |
|
|
|||||
| Total Current Assets | 426.03M | 485.46M | 541.13M | 443.11M | 438.50M |
| Net Property, Plant & Equipment | 10.37M | 6.47M | 6.87M | 7.31M | 7.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 201.22M | 184.44M | 173.05M | 178.52M | 152.22M |
| Total Assets | 814.88M | 836.65M | 823.61M | 801.72M | 846.46M |
|
|
|||||
| Total Accounts Payable | 33.31M | 40.44M | 34.45M | 23.53M | 27.95M |
| Total Accrued Expenses | 102.11M | 117.64M | 125.86M | 113.24M | 110.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.63M | 1.08M | 1.05M | 1.02M | 984.00K |
| Total Finance Division Other Current Liabilities | 12.14M | 6.91M | 10.91M | 6.88M | 4.03M |
| Total Other Current Liabilities | 12.14M | 6.91M | 10.91M | 6.88M | 4.03M |
| Total Current Liabilities | 149.19M | 166.09M | 172.27M | 144.66M | 143.07M |
|
|
|||||
| Total Current Liabilities | 149.19M | 166.09M | 172.27M | 144.66M | 143.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.01M | 5.02M | 5.31M | 5.59M | 5.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.70M | 17.74M | 14.13M | 15.68M | 14.25M |
| Total Liabilities | 176.89M | 188.85M | 191.71M | 165.93M | 163.17M |
|
|
|||||
| Common Stock & APIC | 1.00B | 968.74M | 933.75M | 901.00M | 863.00M |
| Retained Earnings | 611.63M | 643.39M | 619.10M | 599.43M | 564.28M |
| Treasury Stock & Other | -975.77M | -964.32M | -920.95M | -864.64M | -744.00M |
| Total Common Equity | 637.99M | 647.81M | 631.90M | 635.79M | 683.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 637.99M | 647.81M | 631.90M | 635.79M | 683.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 637.99M | 647.81M | 631.90M | 635.79M | 683.29M |
|
|
|||||